Table 3.
Treatment1 | P-value | |||||
---|---|---|---|---|---|---|
CON | SCFP14 | SCFP28 | SEM2 | Linear | Quadratic | |
Red blood cell lysate | ||||||
Superoxide dismutase3,4 | ||||||
Day 0 | 19.5 | 22.2 | 19.7 | – | – | – |
Day 27 | 9.8 | 9.4 | 9.8 | 0.66 | 0.95 | 0.60 |
Day 56 | 12.0 | 9.8 | 11.0 | 0.45 | 0.11 | 0.004 |
Plasma | ||||||
Malondialdehyde, µM4 | ||||||
Day 0 | 3.7 | 4.0 | 4.1 | – | – | – |
Day 27 | 3.5 | 3.9 | 4.1 | 0.24 | 0.09 | 0.80 |
Day 56 | 4.5 | 4.0 | 4.3 | 0.22 | 0.55 | 0.13 |
1CON = Original XPC (Diamond V, Cedar Rapids, IA) at 0 g·steer−1·d−1; SCFP14 = Original XPC at 14 g·steer−1·d−1; SCFP28 = Original XPC at 28 g·steer−1·d−1.
2Highest SEM of any treatment is reported.
3Superoxide dismutase activity; one unit of SOD activity (U) is defined as the enzyme required to dismutate 50% of the superoxide radical; reported as 1,000 U·g hemoglobin−1.
4Day 0 values used as a covariate in analysis.